$NORD
Nordicus Partners Corp

2022 Q3 Form 10-Q Financial Statement

#000149315222024151 Filed on August 26, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $47.00K $5.035M $53.00K
YoY Change -68.03% 7197.1% -47.0%
Operating Profit -$47.00K -$5.035M
YoY Change -68.03% 7197.1%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$47.00K -$5.035M -$53.00K
YoY Change -68.03% 10612.77% -47.0%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$47.00K -$5.035M -$53.00K
YoY Change -68.03% 10612.77% -47.0%
Net Earnings / Revenue
Basic Earnings Per Share -$0.01 -$0.89
Diluted Earnings Per Share -$8.273K -$886.2K -$30.95K
COMMON SHARES
Basic Shares Outstanding 5.681M shares 5.681M shares
Diluted Shares Outstanding 5.681M shares 5.681M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.000K $186.0K $246.0K
YoY Change -66.67% 279.59% 92.19%
Cash & Equivalents $1.000K $186.0K $246.0K
Short-Term Investments
Other Short-Term Assets $9.000K $2.000K $4.000K
YoY Change
Inventory
Prepaid Expenses $9.000K $2.000K $4.000K
Receivables
Other Receivables
Total Short-Term Assets $10.00K $188.0K $250.0K
YoY Change 233.33% 283.67% 95.31%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $10.00K $188.0K $250.0K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $10.00K $188.0K $250.0K
YoY Change 233.33% 283.67% 95.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.00K $7.000K $43.00K
YoY Change -80.87% -50.0% -6.52%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $28.00K $18.00K $55.00K
YoY Change -75.65% 28.57% 19.57%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $28.00K $18.00K $55.00K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $28.00K $18.00K $55.00K
YoY Change -75.65% 28.57% 19.57%
SHAREHOLDERS EQUITY
Retained Earnings -$38.81M -$38.76M -$33.73M
YoY Change
Common Stock $6.000K $6.000K $6.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $30.00K $30.00K $30.00K
YoY Change
Treasury Stock Shares 1.534K shares 1.534K shares 1.534K shares
Shareholders Equity -$18.00K $170.0K $195.0K
YoY Change
Total Liabilities & Shareholders Equity $10.00K $188.0K $250.0K
YoY Change 233.33% 283.67% 95.31%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$47.00K -$5.035M -$53.00K
YoY Change -68.03% 10612.77% -47.0%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$44.00K -$60.00K -$76.00K
YoY Change -4.35% -24.05% 49.02%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -141.0K 200.0K
YoY Change
NET CHANGE
Cash From Operating Activities -44.00K -$60.00K -76.00K
Cash From Investing Activities
Cash From Financing Activities -141.0K 200.0K
Net Change In Cash -185.0K -$60.00K 124.0K
YoY Change 302.17% -24.05% -343.14%
FREE CASH FLOW
Cash From Operating Activities -$44.00K -$60.00K -$76.00K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
usd
CY2021Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
CY2021Q2 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
usd
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
0-28034
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
EKIMAS CORPORATION
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3186647
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
3651 Lindell Road
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001011060
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2022Q2 ASNB Transaction Fee
TransactionFee
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite D565
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89103
CY2022Q2 dei City Area Code
CityAreaCode
(424)
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
256-8560
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
true
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5681248 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
186000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
246000 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2000 usd
CY2022Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
4000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
188000 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
250000 usd
CY2022Q2 us-gaap Assets
Assets
188000 usd
CY2022Q1 us-gaap Assets
Assets
250000 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7000 usd
CY2022Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
43000 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
11000 usd
CY2022Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
12000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
18000 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
55000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
18000 usd
CY2022Q1 us-gaap Liabilities
Liabilities
55000 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5682782 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5682782 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5681248 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5681248 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
6000 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
6000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
38954000 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
33944000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38760000 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33725000 usd
CY2022Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
1534 shares
CY2022Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1534 shares
CY2022Q2 us-gaap Treasury Stock Value
TreasuryStockValue
30000 usd
CY2022Q1 us-gaap Treasury Stock Value
TreasuryStockValue
30000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
170000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
195000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
188000 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
250000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
5035000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
69000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5035000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-69000 usd
CY2021Q2 ASNB Transaction Fee
TransactionFee
-22000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5035000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-47000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5035000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-47000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.89
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5681248 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
566773 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
82000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-47000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
35000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
195000 usd
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
5010000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5035000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
170000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5035000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-47000 usd
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
5010000 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-2000 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-36000 usd
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-32000 usd
CY2022Q2 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-1000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60000 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-79000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-60000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-79000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
246000 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
128000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
186000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
49000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-5035000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-47000 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-60000 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-79000 usd
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6000000 shares
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.00
CY2022Q2 ASNB Preferred Stock Issued And Redeemed Shares
PreferredStockIssuedAndRedeemedShares
500000 shares
CY2021Q2 us-gaap Cash
Cash
22000 usd
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q2 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
0 usd
CY2021Q2 us-gaap Income Tax Credits And Adjustments
IncomeTaxCreditsAndAdjustments
0 usd
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.270 pure
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.270 pure
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
6000000 shares
CY2022Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.00
CY2022Q2 ASNB Common Stock Value Per Share
CommonStockValuePerShare
1.22
CY2022Q2 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
5010000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1500000 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.25

Files In Submission

Name View Source Status
0001493152-22-024151-index-headers.html Edgar Link pending
0001493152-22-024151-index.html Edgar Link pending
0001493152-22-024151.txt Edgar Link pending
0001493152-22-024151-xbrl.zip Edgar Link pending
asnb-20220630.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
asnb-20220630_cal.xml Edgar Link unprocessable
asnb-20220630_lab.xml Edgar Link unprocessable
asnb-20220630_def.xml Edgar Link unprocessable
asnb-20220630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed